Academic Journal
Quartile not availableThe Prostate
About The Prostate
About The Prostate
The Prostate is a peer-reviewed scholarly journal published by Wiley.
Key indicators: ISSN 02704137, 10970045.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
Publishing in The Prostate
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of The Prostate?
02704137, 10970045.
Who publishes The Prostate?
Wiley.
Where do I submit to The Prostate?
Via the official website.
Is The Prostate peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Issue Information
2026-11 · DOI: 10.1002/pros.70257Real‐World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON‐3 Study
Lorena Incorvaia, Veronica Mollica, Ondřej Fiala, Kazutoshi Fujita et al.
2026-10-12 · DOI: 10.1002/pros.70269Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease
Ethan Lo, Alisa Clein, Michael Tam, Sara Trimble et al.
2026-10-11 · DOI: 10.1002/pros.70267Exploratory Analysis of Peri‐Prostatic Adipose Tissue Radiomics Features and Their Potential to Predict Prostate Cancer Diagnosis: Results From a UK Biobank Study
Angela O'Neill, Ryan O'Keeffe, Sarah Winter, Jade Dorrian et al.
2026-10-08 · DOI: 10.1002/pros.70226Defining ‘Freehand’ by Needle Control, Not Probe Stabilization: A Response to the Proposal of a Stepper‐Stabilized Category
Pedro Ivo C. Ravizzini, Luis Silva, Victor Arthur G. Valdo, Daniel A. Rangel et al.
2026-10-06 · DOI: 10.1002/pros.70263Human Prostate Cell Lines: Derivation, Molecular Characteristics and Appropriate Use
Hamza Abohamra, Keenau Mark Pearce
2026-10-06 · DOI: 10.1002/pros.70248Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG‐1216 Phase 3 Trial
Nicolas Sayegh, Yeonjung Jo, Umang Swami, Varun Nandakumar et al.
2026-10-06 · DOI: 10.1002/pros.70266Urinary Soluble Collagen Levels Are Associated With Moderate/Severe LUTS
Marissa Sarna‐McCarthy, Claweens Quetant, Quentin D'Arcy, Richard Caesar et al.
2026-10-06 · DOI: 10.1002/pros.70258Stage‐Specific Racial Disparities in Prostate Cancer Survival Outcomes
Tsion Zewdu Minas, Eboneé Nicole Butler, Samuel Mwakisha Mwamburi, Tiffany H. Dorsey et al.
2026-10-06 · DOI: 10.1002/pros.70265Insulin‐Like Growth Factor Axis and Survival in Metastatic Hormone‐Sensitive Prostate Cancer: Post‐Hoc Analysis From the ENZAMET Phase 3 Trial
Michael A. Cilento, Hui‐Ming Lin, Nicole Yeung, Rachel M.N. Kim et al.
2026-09-27 · DOI: 10.1002/pros.70245Real‐World Landscape of BRCA Deleterious Alterations in Advanced Prostate Cancer: Insights From a Nationwide Genomic Database
Hideyasu Tsumura, Dai Koguchi, Ken‐ichi Tabata, Izuru Shiba et al.
2026-09-27 · DOI: 10.1002/pros.70260Androgen Receptor‐Immune Crosstalk in Metastatic Castration‐Resistant Prostate Cancer: From Context‐Dependent Remodeling to Biomarker‐Guided Translation
Linjie Li, Ruixi Feng, Bingyang Zha, Shiqi Yang et al.
2026-09-27 · DOI: 10.1002/pros.70254Is a Few Too Many? Alcohol Consumption and Prostate Cancer Upgrading During Active Surveillance
Jack Campbell, Michelle I. Higgins, Zhuo Tony Su, Yuezhou Jing et al.
2026-09-27 · DOI: 10.1002/pros.70259NCCN Risk Groups Do Not Predict Adverse Pathology or Oncologic Outcomes Among Patients With Grade Group 1 Prostate Cancer in the MRI Era
Eric V. Li, Tae‐Hee Kim, Michael K. Wang, Jamie O'Byrne et al.
2026-09-27 · DOI: 10.1002/pros.70261Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes
Junliang Zhao, Yuanwei Li, Xinyang Cai, Diwei Zhao et al.
2026-09-19 · DOI: 10.1002/pros.70250Comparison of Gene Enrichment Between Prostate Tissue and Urine for Non‐Invasive Biomarker Development
Yuandong Xing, Minqi Xu, Dan Dion, Vanessa F. Bratti et al.
2026-09-19 · DOI: 10.1002/pros.70251Cross‐Cohort Characterization of an LHB‐Associated Transcriptomic State in Prostate Cancer
Zhihua Pan, Jinjiang Fan, Lidian Zhang, Ruizhe Zhao et al.
2026-09-19 · DOI: 10.1002/pros.70256Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration‐Resistant Prostate Cancer
Meghana Yellanki, Jennifer La, Danne C. Elbers, Nhan V. Do et al.
2026-09-17 · DOI: 10.1002/pros.70247Histological Prostatic Inflammation Is Associated With Storage Lower Urinary Tract Symptoms and Inflammatory/Fibrotic Marker Expression in Benign Prostate Biopsies
Naoya Okubo, Minoru Kobayashi, Kazuyuki Ishida, Takao Kamai et al.
2026-09-13 · DOI: 10.1002/pros.70252Reviews
Community Reviews
Version History
October 10, 2026 at 6:12 pm
October 9, 2026